BioPharma
Regeneron Looks to Infusing More Funds into Gene Editing
Regeneron Pharmaceuticals is going ahead and investing more funds into gene editing, as it has announced a collaboration with Tessera Therapeutics in December 2025, so as to create an experimental program pertaining to rare liver and lung disease.
At the...
BioPharma
Trump To Exempt UK-Origin Pharmaceuticals from Tariffs
The Trump administration has lined up yet another country-specific trade agreement, and this time it is going to be with the U.K., which confers the biggest break on pharmaceutical import tariffs yet with Washington.
For its part, the U.K., which...
News
How Poor Medical Care in Nursing Homes Leads to Preventable Health Complications
Older adults in nursing homes rely on consistent, accurate medical care to stay healthy. Simple health issues can turn into serious complications when that care falls below basic standards. Many of these problems develop slowly and become dangerous before...
News
Addressing Industrial Health Risks: Pharma’s Key Role
Workers in various industries face significant health risks due to exposure to hazardous chemicals, toxic materials, and unsafe working conditions. These risks can lead to severe long-term health problems that affect individual well-being and overall workforce productivity.
Pharmaceutical companies play...
BioPharma
Azerbaijan, Jordan Explore Joint Pharmaceutical Venture
Azerbaijan and Jordan are looking out for new opportunities in order to establish a joint pharmaceutical venture, thereby signalling a very robust step towards much deeper economic cooperation.
As per Azernews, this occurrence was highlighted by Yarub Al-Guda, the Jordanian...
BioPharma
India, Switzerland Discuss Pharma and Biotech Collaboration
Piyush Goyal, the Commerce and Industry Minister, met Helene Budliger Artieda, the visiting Swiss State Secretary for Economic Affairs, and discussed cooperation when it comes to research and development as well as pharma and biotech collaboration with a view...
News
Iraq To Open Largest Cancer Drug Factory in The Region
Iraq looks forward to inaugurating the region’s largest cancer drug factory in Abu Ghraib, which is situated 32 kilometers – equivalent to 20 miles west of Baghdad, in December 2025 at a cost of around 50 million euros.
This step...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















